Literature DB >> 17822672

S731 in the transactivation domain modulates STAT5b activity.

Amanda M Weaver1, Corinne M Silva.   

Abstract

As mediators of cytokine and growth factor signaling, signal transducers and activators of transcription (STATs) transmit signals from the membrane and cytoplasm to the nucleus. While Y699 phosphorylation is required for STAT5b transcriptional activity, our previous studies show that mutation of two tyrosines in the transactivation domain of STAT5b (Y740/743F) increases Y699 phosphorylation leading to increased transcriptional activity and DNA synthesis in breast cancer cells [A.M. Weaver, C.M. Silva, Modulation of signal transducer and activator of transcription 5b activity in breast cancer cells by mutation of tyrosines within the transactivation domain, Molecular Endocrinology 20 (2006) 2392-2405]. In many instances, phosphorylation of serines in the transactivation domain also modulates STAT5b activity. Here, we demonstrate for the first time that EGF stimulation enhances S731 phosphorylation. Furthermore, we show that the increased activity of the Y740/743F STAT5b mutant requires S731. As STAT5b is implicated in several cancers, understanding how its activity is regulated through tyrosine and serine phosphorylation is vital for the development of potential novel cancer therapeutics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17822672      PMCID: PMC2041903          DOI: 10.1016/j.bbrc.2007.08.087

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

Review 1.  Stats: transcriptional control and biological impact.

Authors:  David E Levy; J E Darnell
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

2.  Novel activation of STAT5b in response to epidermal growth factor.

Authors:  Michael T Kloth; Andrew D Catling; Corinne M Silva
Journal:  J Biol Chem       Date:  2001-12-20       Impact factor: 5.157

3.  Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity.

Authors:  S H Park; H Yamashita; H Rui; D J Waxman
Journal:  Mol Endocrinol       Date:  2001-12

4.  STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor.

Authors:  Michael T Kloth; Kristen K Laughlin; Jacqueline S Biscardi; Julie L Boerner; Sarah J Parsons; Corinne M Silva
Journal:  J Biol Chem       Date:  2002-11-11       Impact factor: 5.157

5.  Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).

Authors:  B N Friedrichsen; E D Galsgaard; J H Nielsen; A Møldrup
Journal:  Mol Endocrinol       Date:  2001-01

Review 6.  Serine phosphorylation of STATs.

Authors:  T Decker; P Kovarik
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

Review 7.  Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.

Authors:  Ralf Buettner; Linda B Mora; Richard Jove
Journal:  Clin Cancer Res       Date:  2002-04       Impact factor: 12.531

8.  Regulation of erythropoietin-induced STAT serine phosphorylation by distinct mitogen-activated protein kinases.

Authors:  Rizwan Haq; Adrienne Halupa; Bryan K Beattie; Jacqueline M Mason; Brent W Zanke; Dwayne L Barber
Journal:  J Biol Chem       Date:  2002-03-01       Impact factor: 5.157

9.  Role of serine phosphorylation of Stat5a in prolactin-stimulated beta-casein gene expression.

Authors:  H Yamashita; M T Nevalainen; J Xu; M J LeBaron; K U Wagner; R A Erwin; J M Harmon; L Hennighausen; R A Kirken; H Rui
Journal:  Mol Cell Endocrinol       Date:  2001-10-25       Impact factor: 4.102

10.  Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6.

Authors:  Amanda M Weaver; Corinne M Silva
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more
  6 in total

1.  Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformation.

Authors:  Katrin Friedbichler; Marc A Kerenyi; Boris Kovacic; Geqiang Li; Andrea Hoelbl; Saliha Yahiaoui; Veronika Sexl; Ernst W Müllner; Sabine Fajmann; Sabine Cerny-Reiterer; Peter Valent; Hartmut Beug; Fabrice Gouilleux; Kevin D Bunting; Richard Moriggl
Journal:  Blood       Date:  2010-05-27       Impact factor: 22.113

2.  Hepatic growth hormone resistance after acute injury.

Authors:  Ryan M Corrick; Li Li; Stuart J Frank; Joseph L Messina
Journal:  Endocrinology       Date:  2013-02-15       Impact factor: 4.736

3.  Forskolin-inducible cAMP pathway negatively regulates T-cell proliferation by uncoupling the interleukin-2 receptor complex.

Authors:  Georgialina Rodriguez; Jeremy A Ross; Zsuzsanna S Nagy; Robert A Kirken
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

Review 4.  The different functions of Stat5 and chromatin alteration through Stat5 proteins.

Authors:  Jan-Wilhelm Kornfeld; Florian Grebien; Marc A Kerenyi; Katrin Friedbichler; Boris Kovacic; Barbara Zankl; Andrea Hoelbl; Harini Nivarti; Hartmut Beug; Veronika Sexl; Mathias Muller; Lukas Kenner; Ernst W Mullner; Fabrice Gouilleux; Richard Moriggl
Journal:  Front Biosci       Date:  2008-05-01

Review 5.  STAT heterodimers in immunity: A mixed message or a unique signal?

Authors:  Greg M Delgoffe; Dario A A Vignali
Journal:  JAKSTAT       Date:  2013-01-01

Review 6.  STAT5A and STAT5B-Twins with Different Personalities in Hematopoiesis and Leukemia.

Authors:  Barbara Maurer; Sebastian Kollmann; Judith Pickem; Andrea Hoelbl-Kovacic; Veronika Sexl
Journal:  Cancers (Basel)       Date:  2019-11-04       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.